hsa-miR-181a-3p can directly downregulate ZBTB33 expression; therefore, it inhibits the expansion, growth, invasions, and unspecialized epithelial transition of glioma tumor cells [34]. The gene discussed is ZBTB33; the disease is central nervous system cancer.